<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Tasmar; Tolcapone" /><meta name="IX" content="Tasmar; Tolcapone" /><title>Tasmar®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="129263.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="129263.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=129263.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3631.htm">4.9 Drugs used in parkinsonism and related disorders</a> &gt; <a href="3632.htm">4.9.1 Dopaminergic drugs used in Parkinson’s disease</a> &gt; <a href="129830.htm">Catechol-<i>O</i>-methyltransferase inhibitors</a> &gt; <a href="129262.htm">TOLCAPONE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="73633.htm" title="Previous: ENTACAPONE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129831.htm" title="Next: Amantadine">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a398036.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Antiparkinsonian Agents 28:36 &gt; Catechol-O-Methyltransferase (COMT) Inhibitors 28:36.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/15928-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Tolcapone</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: T &gt; Interactions of Tolcapone</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="129830.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Catechol-O-methyltransferase inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease</p></div></li><li><a href="129262.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">TOLCAPONE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease &gt; Catechol-O-methyltransferase inhibitors</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/15928-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiparkinsonian Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09508.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolcapone</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; T &gt; TO</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D861.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Tolcapone</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; T</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_129262">TOLCAPONE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i1042.htm" title="Go to appendix 1">Tolcapone</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">adjunct to co-beneldopa or co-careldopa in Parkinson’s disease with
‘end-of-dose’ motor fluctuations if another inhibitor of peripheral
catechol-<i>O</i>-methyltransferase inappropriate (under
specialist supervision)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">avoid abrupt withdrawal; most patients receiving more than 600 mg levodopa
daily require reduction of levodopa dose by about 30%; <b>interactions:</b> Appendix 1 (tolcapone) </p><div class="cAV"><h3>Hepatotoxicity</h3> <p class="cAX">Potentially life-threatening
hepatotoxicity including fulminant hepatitis reported rarely, usually
in women and during the first 6 months, but late-onset liver injury
also reported; test liver function before
treatment, and monitor every 2 weeks for first year, every 4 weeks
for next 6 months and then every 8 weeks thereafter (restart monitoring
schedule if dose increased); discontinue
if abnormal liver function tests or symptoms of liver disorder (counselling, see below); do not re-introduce tolcapone
once discontinued</p></div><div class="cAV"><h3>Counselling</h3> <p class="cAX">Patients should be told
how to recognise signs of liver disorder and advised to seek immediate
medical attention if symptoms such as anorexia, nausea, vomiting,
fatigue, abdominal pain, dark urine, or pruritus develop</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">severe dyskinesia, phaeochromocytoma, previous history of
neuroleptic malignant syndrome, rhabdomyolysis, or hyperthermia</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">avoid; see also under Cautions</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">caution if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">toxicity in <i>animal</i> studies—use only
if potential benefit outweighs risk</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">avoid—present in milk in <i>animal</i> studies</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">diarrhoea, constipation, dyspepsia, abdominal
pain, nausea, vomiting, anorexia, xerostomia, hepatotoxicity (see
above); chest pain; confusion, dystonia, dyskinesia, drowsiness, headache,
dizziness, sleep disturbances, excessive dreaming, hallucinations;
syncope; urine discoloration; sweating; neuroleptic malignant syndrome
and rhabdomyolysis reported on dose reduction or withdrawal</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">100 mg 3 times daily, leave 6 hours between each dose;
max. 200 mg 3 times daily in exceptional circumstances; first daily
dose should be taken at the same time as levodopa with dopa-decarboxylase
inhibitor</p><div class="cAT"><h3>Note</h3> <p class="cAX">Continue beyond 3 weeks <b>only</b> if substantial improvement</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_129263" style="margin: 0 0 0 20px;"><h1 class="title">Tasmar®<span> (<a href="appendix-112803-M.htm#m597">Meda</a>)</span> <a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_s.png" alt="Black triangle" /></a> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Tablets</span>, f/c, yellow, tolcapone
100 mg, net price 100-tab pack = £95.20. 
    Label:
    14, 25</div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="73633.htm">Previous: ENTACAPONE</a> | <a class="top" href="129263.htm#">Top</a> | <a accesskey="]" href="129831.htm">Next: Amantadine</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>